このエントリーをはてなブックマークに追加


ID 68693
フルテキストURL
fulltext.pdf 2.15 MB
著者
Naganuma, Miyako Division of Organic Chemistry, National Institute of Health Sciences
Tsuji, Genichiro Division of Organic Chemistry, National Institute of Health Sciences
Amiya, Misato YMC CO., LTD.
Hirai, Reira YMC CO., LTD.
Higuchi, Yuki YMC CO., LTD.
Hata, Naoko YMC CO., LTD.
Nozawa, Saoko YMC CO., LTD.
Watanabe, Daishi Division of Organic Chemistry, National Institute of Health Sciences
Nakajima, Taeko YMC CO., LTD.
Demizu, Yosuke Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Division of Pharmaceutical Science, Okayama University
抄録
Peptide-oligonucleotide conjugates (POCs) are chimeric molecules that combine the specificity of oligonucleotides with the functionality of peptides, improving the delivery and therapeutic potential of nucleic acid-based drugs. However, the analysis of POCs, particularly those containing arginine-rich sequences, poses major challenges because of aggregation caused by electrostatic interactions. In this study, we developed an optimized high-performance liquid chromatography (HPLC) method for analyzing POCs. Using a conjugate of DNA and nona-arginine as a model compound, we systematically investigated the effects of various analytical parameters, including column type, column temperature, mobile-phase composition, and pH. A column packed with C18 resin with wide pores combined with butylammonium acetate as the ion-pairing reagent and an optimal column temperature of 80 degrees C provided superior peak resolution and sensitivity. The optimized conditions gave clear separation of POCs from unlinked oligonucleotides and enabled the detection of nucleic acid fragments lacking an alkyne moiety as a linkage part, which is critical for quality control. Our HPLC method is robust and reproducible and substantially reduces the complexity, time, and cost associated with the POC analysis. The method may improve the efficiency of quality control in the production of POCs, thereby supporting their development as promising therapeutic agents for clinical applications.
発行日
2025-04-30
出版物タイトル
ACS Omega
出版者
American Chemical Society
ISSN
2470-1343
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2025 The Authors.
論文のバージョン
publisher
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1021/acsomega.5c01308
ライセンス
https://creativecommons.org/licenses/by-nc-nd/4.0/
助成機関名
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science
YMC CO., LTD.
助成番号
24mk0121286
24ama221127
24ak0101185
21K05320
23H04926
21J23036